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Introduction {#sec1}
============

Distinctions in membrane lipid composition establish organelle identity in eukaryotic cells ([@bib7]). For example, the endoplasmic reticulum (ER) and plasma membrane (PM) have notably different lipid compositions ([@bib49]). The cytoplasmic leaflet of the ER membrane is defined by low sterol content and is high in unsaturated phospholipids. In contrast, the cytoplasmic leaflet of the PM is enriched in distinct lipids that serve as hallmarks for its identity, including sterols and the anionic phospholipid phosphatidylserine (PS). Among the phospholipids, phosphatidylinositol (4,5)-bisphosphate \[PI(4,5)P~2~\] is another key determinant for PM identity and function ([@bib4], [@bib15]). PI(4,5)P~2~ has vital roles in many events at the PM, including exocytosis, endocytosis, cytoskeletal dynamics, cytokinesis, ion channel regulation, and the generation of second messenger molecules ([@bib4], [@bib15]). Yet, although physiological roles for PI(4,5)P~2~ at the PM have been intensely studied, less is known about the regulation of PI(4,5)P~2~ metabolism.

Heterogeneous lipid distribution must also be considered in understanding PM organization ([@bib21]). Biological membranes are not homogeneous, and lipids are not uniformly distributed within a membrane. Differences in the physical properties of lipids are proposed to induce membrane lipid segregation and the formation of lipid nanodomains ([@bib18], [@bib37]). Accordingly, although lipid composition per se is not fully conserved across organisms, the biophysical principles that govern membrane organization are universally applied ([@bib30], [@bib56]). As such, it is apparent that lipid heterogeneity contributes to sub-compartmental organization and that lipid organizing principles have advantages in vital functions of the PM ([@bib18]).

Selective lipid transport tends to increase lipid heterogeneity and, thus, distinct membrane environments ([@bib2], [@bib7]). A conserved family of lipid exchange proteins, the oxysterol-binding protein related proteins (ORPs), is thought to transfer lipids, including PS and sterols from the ER to the PM or to late Golgi and secretory compartments in exchange for phosphatidylinositol 4-phosphate (PI4P) ([@bib10], [@bib14], [@bib43], [@bib44]). ORP function is critical for cell growth and survival ([@bib9]). Accordingly, deletion of all four ORP genes in *C. elegans* is embryonic lethal upon cholesterol restriction ([@bib34]). Likewise, yeast cells lacking the ORP-related Osh proteins (oxysterol-binding protein homology) are inviable and are impaired in endocytosis ([@bib5]), polarized secretion ([@bib1]), PI4P metabolism ([@bib54]) and sterol organization in the PM ([@bib19]). However, ORP/Osh protein function is controversial ([@bib42]) and the essential role for ORP-mediated lipid exchange remains unknown.

We find that the Osh proteins are critical for PI(4,5)P~2~ synthesis. Quantitative lipidomics and microscopy show that PI(4,5)P~2~ and PS levels are severely reduced upon Osh protein inactivation. PI4P 5-kinase (PIP5K) shows increased activity against PI4P in the presence of unsaturated PS and this effect is markedly enhanced by sterols. Accordingly, FRET analyses imply that unsaturated PS and PI4P co-distribute in the presence of sterols. Finally, *in vivo* imaging and molecular dynamics (MD) simulations suggest that the specificity loop of PIP5K is a lipid sensor that ensures high PIP5K activity at the PM. Thus, Osh protein-mediated lipid exchange results in nanoscale membrane lipid environments necessary for PIP5K activity that controls global PM domain organization and dynamic PM events including exocytosis and endocytosis.

Results {#sec2}
=======

Osh Proteins and ER-PM Contacts Control PI(4,5)P~2~ Synthesis {#sec2.1}
-------------------------------------------------------------

PM identity is defined by its specialized lipid composition. In particular, PI4P and PI(4,5)P~2~ are important phosphoinositide lipid species in the PM and both regulate essential processes at the PM ([@bib4]). Because the ORP/Osh proteins share conserved functions in PI4P binding and metabolism ([@bib14], [@bib29], [@bib44], [@bib54]), we reasoned they may control PI4P use (i.e., in lipid exchange reactions and PI(4,5)P~2~ synthesis) and, thus, PM organization. To test this, we used *osh1-7*Δ*/osh4*^*ts*^ mutant yeast cells that lack the *OSH1*--*OSH7* genes and carry a temperature-sensitive *osh4-1* allele ([@bib5]). We first examined whether Osh proteins maintain PM integrity by using propidium iodide that does not penetrate membranes and enters cells only upon loss of PM integrity. Upon brief PM stress conditions, more than 40% of *osh1-7*Δ*/osh4*^*ts*^ cells scored as propidium iodide positive, whereas wild-type cells exhibited negligible staining ([Figure 1](#fig1){ref-type="fig"}A). We also examined PM domain organization by monitoring the PI(4,5)P~2~-binding protein Pil1, a major component of PM structures termed eisosomes ([@bib32]). Pil1-GFP was observed at cortical sites in wild-type cells but accumulated in intracellular puncta in *osh1-7*Δ*/osh4*^*ts*^ cells ([Figure 1](#fig1){ref-type="fig"}B). Thus, both PM integrity and organization are significantly affected in *osh1-7*Δ*/osh4*^*ts*^ cells. Based on the observation that similar defects have been observed in cells with impaired PIP5K activity ([@bib32], [@bib47]), we wondered if Osh proteins might regulate PI(4,5)P~2~ synthesis.Figure 1Osh Proteins Maintain PI(4,5)P~2~ and PS Levels at the PM(A) PM integrity of wild-type and *osh1-7Δ*/*osh4*^*ts*^ cells. Cells incubated at 26°C or 42°C for 15 min were stained with propidium iodide and analyzed by flow cytometry. Data represent the mean ± SEM (n = 3).(B) Pil1-GFP localization in wild-type and *osh1-7Δ*/*osh4*^*ts*^ cells.(C) PI(4,5)P~2~ (GFP-2xPH~PLCδ~) and PS (GFP-C2~Lact~) FLARE localization in wild-type and *osh1-7Δ*/*osh4*^*ts*^ cells.(B and C) Cells were shifted to 38°C for 2 h. Scale bars, 4 μm.(D and E) Quantitation of GFP-2xPH~PLCδ~ (D) and GFP-C2~Lact~ (E) signals in the PM. Relative PM and cytosolic signals were measured as described in [STAR Methods](#sec4){ref-type="sec"}. Data represent mean ± SD (n ≥ 20 cells).(F--H) Lipidomic analysis of PIP (F), PIP~2~ (G), and PS (H) in cells cultured at 26°C or 38°C for 2 h. Data represent mean ± SEM (n = 5).(I--K) Measurements of inositol incorporation and PI synthesis (I), synthesis of the PIP~2~ variants PI(3,5)P~2~ and PI(4,5)P~2~ (J), and synthesis of the PIP variants PI3P and PI4P (K) as monitored by ^3^H-inositol labeling and HPLC analysis of cells cultured at 38°C for 1 h. Data represent the mean ± SEM (n = 3).^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

We investigated whether the Osh proteins control PI(4,5)P~2~ localization and levels. PM localization of the PI(4,5)P~2~ FLARE (fluorescent lipid-associated reporter) GFP-2xPH~PLCδ~ was significantly reduced in *osh1-7*Δ*/osh4*^*ts*^ cells at the restrictive temperature ([Figures 1](#fig1){ref-type="fig"}C and 1D). We also measured phosphoinositide levels by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) analysis ([@bib11]). Mono-phosphorylated phosphatidylinositol (PIP) was significantly increased in *osh1-7*Δ*/osh4*^*ts*^ cells at the restrictive temperature (38°C; [Figure 1](#fig1){ref-type="fig"}F). In contrast, the level of phosphatidylinositol bis-phosphate (PIP~2~) was drastically reduced ([Figure 1](#fig1){ref-type="fig"}G), consistent with the microscopy results ([Figures 1](#fig1){ref-type="fig"}C and 1D). To further define changes in phosphoinositide metabolic flux, we performed ^3^H-inositol labeling for 1 h and high-performance liquid chromatography (HPLC) analysis. This showed a major reduction in PI(4,5)P~2~ synthesis in *osh1-7*Δ*/osh4*^*ts*^ cells at the restrictive temperature ([Figure S1](#mmc1){ref-type="supplementary-material"}B), but inositol uptake and phosphatidylinositol (PI) synthesis were not dramatically impaired ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Consistent with intact PI production, PI4P synthesis increased by more than an order of magnitude in the mutant cells ([Figure S1](#mmc1){ref-type="supplementary-material"}C), as previously published ([@bib54]). In rescue experiments, PI(4,5)P~2~ synthesis was restored by expression of wild-type Osh4 from a plasmid ([Figure S1](#mmc1){ref-type="supplementary-material"}E). In contrast, mutant forms of Osh4 impaired in PI4P binding (Osh4HH143,144AA and Osh4Δ29) ([@bib14], [@bib45]) did not rescue PI(4,5)P~2~ synthesis ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Likewise, expression of wild-type, but not mutant, Osh4 decreased PI4P in *osh1-7*Δ*/osh4*^*ts*^ cells ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Notably, the labeling experiments also indicated that PI4P synthesis exceeds PI(4,5)P~2~ synthesis (compare the scales in [Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). This suggests that PI4P may be consumed during Osh-mediated lipid exchange reactions to promote PIP5K activity and PI(4,5)P~2~ production.

The PM contains high concentrations of sterols, and its cytoplasmic leaflet is enriched in certain lipids, including phosphatidylethanolamine (PE) and PS ([@bib7]). Osh6 and Osh7 are proposed to serve as PI4P and PS exchange proteins that transfer newly synthesized PS from the ER to the PM ([@bib44]). Accordingly, the PM intensity of the PS FLARE GFP-C2~Lact~ was significantly reduced in *osh1-7*Δ*/osh4*^*ts*^ cells ([Figures 1](#fig1){ref-type="fig"}C and 1E) even at the permissive temperature of 26°C. Moreover, MS lipid analysis indicated that the amount of PS was significantly reduced in *osh1-7*Δ*/osh4*^*ts*^ cells (by \>50% and \>80% at the permissive and restrictive temperatures, respectively; [Figure 1](#fig1){ref-type="fig"}H). The reduction in PS levels may be due to a negative feedback mechanism in the ER membrane reported for both mammalian and yeast PS synthases ([@bib31], [@bib53]). Independent quantitative lipidomics experiments confirmed that PS levels were significantly reduced in *osh1-7*Δ*/osh4*^*ts*^ cells ([Supplemental Information](#app2){ref-type="sec"}). Interestingly, expression of wild-type Osh6 from a plasmid restored PI, PI4P, and PI(4,5)P~2~ homeostasis ([Figures 1](#fig1){ref-type="fig"}I--1K). In contrast, a mutant form of Osh6 impaired in PI4P binding did not rescue PI(4,5)P~2~ synthesis ([Figure 1](#fig1){ref-type="fig"}J) or PI4P homeostasis ([Figure 1](#fig1){ref-type="fig"}K).

We also examined mutant cells (named Δtether cells) lacking six ER-PM "tether" proteins that accumulate PI4P at the PM ([@bib40]). Similar to *osh1-7*Δ*/osh4*^*ts*^ cells, PM localization of the PI(4,5)P~2~ FLARE mCherry-2xPH~PLCδ~ was reduced in Δtether cells ([Figure S1](#mmc1){ref-type="supplementary-material"}G). Thus, although PI4P accumulates in *osh1-7*Δ*/osh4*^*ts*^ and Δtether cells, it is not an efficient substrate for PIP5K. In addition, the PM fluorescence intensity of the PS FLARE GFP-C2~Lact~ and PS levels were reduced in the Δtether cells compared to wild type ([Figure S1](#mmc1){ref-type="supplementary-material"}H and [Supplemental Information](#app2){ref-type="sec"}). Based on these initial findings, we next considered whether PIP5K selectively uses PI4P in a sterol- and PS-enriched environment formed by Osh proteins and ER-PM contacts.

PS Enhances PIP5K Activity *In Vitro* {#sec2.2}
-------------------------------------

To study the lipid requirements for PIP5K activity, we developed a real-time PIP5K assay by using a PI(4,5)P~2~ sensor, NBD-PH~PLCδ~, to monitor PI(4,5)P~2~ levels on liposomes by fluorescence spectroscopy. As nitrobenzoxadiazole (NBD) displays enhanced fluorescence at 530 nm in a hydrophobic environment, increases in NBD fluorescence intensity (ΔEm530) indicate recruitment of NBD-PH~PLCδ~ to liposomes ([Figure 2](#fig2){ref-type="fig"}A). We confirmed linear increases in NBD-PH~PLCδ~ fluorescence intensity in response to PI(4,5)P~2~ across a dynamic range (0.125--1 mol%; [Figure S2](#mmc1){ref-type="supplementary-material"}A). Recombinant zebrafish PIP5K1A (zPIP5K amino acid \[aa\] 49--431) ([@bib27]) was used for PIP5K assays. Expression of zPIP5K restored the growth defect of yeast PIP5K mutant *mss4*^*ts*^ cells, suggesting zPIP5K recognizes yeast and metazoan lipid species ([Figure S2](#mmc1){ref-type="supplementary-material"}B). In control PIP5K assays, liposomes containing 5 mol% brain-derived PI4P (bPI4P) were mixed with zPIP5K, and NBD-PH~PLCδ~ signal intensity was measured by fluorescence spectroscopy prior to (time = 0 s) and after addition of ATP. The NBD fluorescence intensity rapidly increased in an ATP, Mg^2+^, and zPIP5K dose-dependent manner ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Liposome size did not significantly affect zPIP5K activity in the presence of 5 mol% bPI4P ([Figure S2](#mmc1){ref-type="supplementary-material"}D). We observed zPIP5K activity only at concentrations of bPI4P (3.3 mol% and higher; [Figure S2](#mmc1){ref-type="supplementary-material"}E) that are well above concentrations reported in the PM (\<0.2 mol% of total PM lipids) ([@bib59]). This suggests additional factors promote robust PIP5K activity *in vivo*.Figure 2PS Activates PIP5K *In Vitro*(A) Scheme for the real-time PIP5K assay. NBD-PH~PLCδ~ fluorescence increases upon binding PI(4,5)P~2~ generated by PIP5K on liposomes.(B) Liposomes containing the indicated amount of brain PI4P (bPI4P), brain PS (bPS), and egg PC were mixed with 60 nM zebrafish PIP5K (zPIP5K) and 400 nM NBD-PH~PLCδ~. After addition of ATP, NBD fluorescence was recorded by fluorescence spectroscopy. Data represent mean values (n = 3; SEM \< 1.12 × 10^3^).(C) zPIP5K activity against various PI4P concentrations in the absence and presence of 10 mol% bPS. Initial velocities (Vi) were determined from PIP5K reaction progress curves (shown in [Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F). Data represent the mean ± SEM (n ≥ 3).(D) Measurement of PIP5K activity by the ADP-Glo kinase assay. The formation of ADP produced by PIP5K reactions was detected using bioluminescence.(E) Measurement of PIP5K activity by the ADP-Glo kinase assay (time = 2 min) on liposomes containing the indicated amount of bPI4P, bPS, and egg PC. Data represent mean ± SEM (n = 3).^∗^p \< 0.05, ^∗∗∗^p \< 0.001. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

We, therefore, examined whether PS stimulates PIP5K activity in the real-time PIP5K assay. Interestingly, when liposomes also contained 10 mol% or 20 mol% of brain-derived phosphatidylserine (bPS), PIP5K activity was clearly detected against 2 mol% bPI4P ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}F). For comparison, PS makes up \>30% of phospholipids in the PM of yeast cells ([@bib60]). Consistent with previous work ([@bib50]), phosphatidic acid (PA) also stimulated PIP5K activity, but other phospholipids found in the PM, including PI and PE, did not ([Figure S2](#mmc1){ref-type="supplementary-material"}G). Kinetic analyses confirmed that bPS activates PIP5K ([Figure 2](#fig2){ref-type="fig"}C). The apparent K~m~ value of zPIP5K for PI4P was effectively reduced from 6.2 mol% to 1.5 mol% in the presence of bPS without obvious changes in V~max~ ([Figure 2](#fig2){ref-type="fig"}C). The sensitivity of the PI(4,5)P~2~ sensor also increased in the presence of PS by nearly 2-fold ([Figure S2](#mmc1){ref-type="supplementary-material"}A), but this does not fully account for the 4-fold increase in zPIP5K activity ([Figures 2](#fig2){ref-type="fig"}C, [S2](#mmc1){ref-type="supplementary-material"}E, and S2F). To confirm the positive effect of bPS on zPIP5K activity, we used an ADP-Glo kinase assay that detects ADP produced by the PIP5K kinase reaction ([Figure 2](#fig2){ref-type="fig"}D). ADP formation by PIP5K was significantly increased in the presence of bPS ([Figure 2](#fig2){ref-type="fig"}E). Collectively, these results suggest that PS efficiently enhances PIP5K activity *in vitro*.

Sterol and Unsaturated PS Synergistically Enhance PIP5K Activity {#sec2.3}
----------------------------------------------------------------

We also investigated the effect of sterol lipids shown to bind Osh proteins *in vitro* ([@bib14], [@bib29], [@bib41], [@bib45]). Cholesterol enhanced zPIP5K activity in the real-time PIP5K assay ([Figure 3](#fig3){ref-type="fig"}A) without influencing the sensitivity of the PI(4,5)P~2~ sensor NBD-PH~PLCδ~ ([Figure S3](#mmc1){ref-type="supplementary-material"}A). The apparent K~m~ value of PIP5K for PI4P was reduced from 6.2 mol% to 3.0 mol% in the presence of cholesterol ([Figure 3](#fig3){ref-type="fig"}A). We then analyzed the simultaneous effect of bPS and cholesterol on zPIP5K activity. When the amount of bPI4P in liposomes was reduced to 1 mol%, a positive effect on zPIP5K activity by either bPS or cholesterol alone was weak or not clearly observed ([Figure 3](#fig3){ref-type="fig"}B). In contrast, zPIP5K activity increased dramatically in the presence of both bPS and cholesterol ([Figure 3](#fig3){ref-type="fig"}B). These results suggest that cholesterol and bPS synergistically stimulate PIP5K activity.Figure 3PIP5K Stimulation by Unsaturated PS and Sterols *In Vitro*(A) PI4P concentration dependence of zPIP5K activity in the absence and presence of 20 mol% cholesterol (Chol). Initial velocities (Vi) were determined from PIP5K reaction progress curves from real-time assays. Data represent mean ± SEM (n = 3).(B) The activity of zPIP5K toward 1 mol% bPI4P liposomes either lacking or containing bPS and/or cholesterol as indicated. Data represent mean values (n = 3; SEM \< 0.25 × 10^3^).(C) The activity of zPIP5K toward 1 mol% bPI4P liposomes containing the indicated PS species either lacking or containing cholesterol as indicated. Data represent mean values (n ≥ 6; SEM \< 0.48 × 10^3^).(D) PIP5K sedimentation assays using liposomes containing bPI4P, DOPS, and cholesterol as indicated. Data represent mean ± SEM (n = 3).(E) The activity of zPIP5K toward 1 mol% PO-PI4P liposomes containing the indicated PS species either lacking or containing ergosterol (Erg) as indicated. Data represent mean values (n = 3; SEM \< 1.20 × 10^3^).(F) PIP5K sedimentation assays using 1 mol% PO-PI4P liposomes either lacking or containing the indicated PS and/or Erg. Data represent mean ± SEM (n = 3).(G) Phospholipids used in the PIP5K assays.^∗^p \< 0.05. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

We next investigated whether the fatty acid composition of PS and PI4P affects PIP5K stimulation, as bPS and bPI4P are composed of multiple species including polyunsaturated forms. Compared to saturated di-palmitoyl-phosphatidylserine (16:0/16:0 DPPS), cholesterol was effective in stimulating PIP5K in the presence of mono-unsaturated 1-palmitoyl-2-oleyl-phosphatidylserine (16:0/18:1 POPS) and di-unsaturated di-oleoyl-phosphatidylserine (18:1/18:1 DOPS) ([Figures 3](#fig3){ref-type="fig"}C and 3G). zPIP5K showed the highest activity against bPI4P in the presence of DOPS and cholesterol ([Figure 3](#fig3){ref-type="fig"}C). Cholesterol did not enhance PI(4,5)P~2~ probe sensitivity in the presence of DOPS, and the PI(4,5)P~2~ probe displayed only slight differences in sensitivity under the various conditions ([Figure S3](#mmc1){ref-type="supplementary-material"}B). We also examined the effect of lipid composition on PIP5K membrane affinity and found, in contrast to the PI(4,5)P~2~ probe, that PIP5K binding to 1 mol% bPI4P liposomes increased upon addition of both DOPS and cholesterol ([Figure 3](#fig3){ref-type="fig"}D). In line with the real-time assays, zPIP5K showed the highest activity against bPI4P in the presence of both DOPS and cholesterol in the ADP-Glo kinase assay ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Time course experiments using the ADP-Glo assay confirmed that PIP5K activity occurred rapidly in the presence of DOPS and cholesterol (reaching completion by 120 s; [Figure S3](#mmc1){ref-type="supplementary-material"}G). In contrast, changes in free phosphate levels were negligible and did not increase over the course of the experiment ([Figure S3](#mmc1){ref-type="supplementary-material"}H), confirming that the ADP-Glo assays measured ADP produced by PIP5K-dependent PI(4,5)P~2~ synthesis rather than non-specific ATP hydrolysis. Altogether, these results indicate that PIP5K demonstrates high activity in the presence of DOPS and cholesterol.

Yeast cells do not synthesize polyunsaturated phospholipids or cholesterol (see the [Supplemental Information](#app2){ref-type="sec"} and [Figure 4](#fig4){ref-type="fig"}). However, similar trends were observed with the yeast lipid species 1-palmitoyl-2-oleyl PI4P (16:0/18:1 PO-PI4P) and ergosterol. Ergosterol enhanced PIP5K enzymatic activity and membrane binding against 1 mol% PO-PI4P in the presence of unsaturated PS (DOPS again was most effective; [Figures 3](#fig3){ref-type="fig"}E--3G). Likewise, ergosterol stimulated zPIP5K activity against 1 mol% PO-PI4P liposomes containing unsaturated PS in the ADP-Glo kinase assay (DOPS and ergosterol resulted in the highest activity; [Figure S3](#mmc1){ref-type="supplementary-material"}G). Thus, PIP5K displays high activity in a membrane environment containing sterol and unsaturated PS species. Moreover, the unsaturated PI4P species bPI4P (18:0/20:4) and PO-PI4P (16:0/18:1) were better substrates than saturated di-palmitoyl PI4P (16:0/16:0 DP-PI4P) ([Figure S3](#mmc1){ref-type="supplementary-material"}E), consistent with a previous study ([@bib50]). Finally, PIP5K showed robust activity against liposomes containing physiological levels of PO-PI4P (0.2 mol%) and additional lipids resembling the composition of the cytoplasmic leaflet of the yeast PM, dependent upon unsaturated PS and ergosterol ([Figure S3](#mmc1){ref-type="supplementary-material"}F). Collectively, our results indicate that PIP5K prefers a membrane lipid environment containing unsaturated PI4P, unsaturated PS, and sterol.Figure 4Fatty Acid Unsaturation of PIP and PS Are Maintained in *osh1-7*Δ*/osh4*^*ts*^ CellsLipidomic analysis of PS and PIP in wild-type and *osh1-7*Δ/*osh4*^*ts*^ cells cultured at 26°C or 38°C for 2 h. Data represent mean ± SEM (n = 5).(A and B) Fatty acid compositions of PS (A) and PIP (B).(C and D) Fatty acid unsaturation degree of PIP (C) and PS (D).^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Fatty Acid Unsaturation of PS and PI4P Are Maintained in *osh1-7*Δ*/osh4*^*ts*^ Cells {#sec2.4}
-------------------------------------------------------------------------------------

Considering that PIP5K prefers unsaturated PI4P and is activated by unsaturated PS, we examined the fatty acid composition of PS, PI, and phosphoinositide species in wild-type and *osh1-7*Δ*/osh4*^*ts*^ cells. The major species of PS, PI, PIP, and PIP~2~ in control cells were unsaturated (mono-unsaturated X:1 and di-unsaturated X:2 where X refers to total acyl chain length), whereas saturated species (X:0) were rare ([Figures 4](#fig4){ref-type="fig"}A, 4B, [S4](#mmc1){ref-type="supplementary-material"}A, and S4B). The most abundant PS and PIP species in wild-type control cells were mono-unsaturated POPS and PO-PI4P (34:1; [Figures 4](#fig4){ref-type="fig"}A and 4B). In *osh1-7*Δ*/osh4*^*ts*^ cells, POPS levels decreased and PO-PI4P levels increased ([Figures 4](#fig4){ref-type="fig"}A and 4B), consistent with the proposed role for Osh6/7 as PI4P and POPS exchange proteins ([@bib44]). Intriguingly, mono-unsaturated PIP~2~ was slightly enriched in comparison to mono-unsaturated PIP and PI in wild-type cells ([Figure S4](#mmc1){ref-type="supplementary-material"}C), suggesting yeast PIP5K may prefer mono-unsaturated PI4P. Although overall PIP levels were increased in *osh1-7*Δ*/osh4*^*ts*^ cells ([Figures 1](#fig1){ref-type="fig"}F and [4](#fig4){ref-type="fig"}B), major changes in acyl chain profiles were not observed. A small portion of PIP shifted from 36:X acyl species (where X refers to any level of unsaturation) to shorter PIP 32:X species in *osh1-7*Δ*/osh4*^*ts*^ cells ([Figure S4](#mmc1){ref-type="supplementary-material"}D). However, the overall degree of PIP unsaturation was not significantly affected in *osh1-7*Δ*/osh4*^*ts*^ cells ([Figure 4](#fig4){ref-type="fig"}C). As such, the distribution of PIP species did not shift toward saturated species that are poor substrates for PIP5K ([Figures 4](#fig4){ref-type="fig"}B and 4C). Likewise, the degree of PS saturation did not increase in *osh1-7*Δ*/osh4*^*ts*^ cells, but instead shifted toward unsaturated species ([Figures 4](#fig4){ref-type="fig"}A and 4D). In sum, these results suggest that Osh function has a minor impact on acyl chain length and saturation of PI4P. Rather, a major function for the Osh proteins may be to create a PM lipid environment containing unsaturated PI4P and PS that is suitable for PIP5K activity.

Unsaturated PS and PI4P May Co-distribute in the Presence of Sterols {#sec2.5}
--------------------------------------------------------------------

Sterols are thought to stably interact with saturated lipids but not with unsaturated lipids ([@bib51]). To evaluate whether sterol lipids affect the distribution of unsaturated PS and PI4P, we designed an *in vitro* FRET (Förster resonance energy transfer) assay ([Figures 5](#fig5){ref-type="fig"}A and 5B). FRET is well suited to evaluate proximity in the nanometer range and can detect the co-assembly of lipids within a membrane bilayer ([@bib51]). The CFP-tagged PS sensor (CFP-C2~Lact~) and Venus-tagged PI4P sensor (Venus-P4C) were mixed with liposomes of defined compositions, and the FRET signal was measured ([Figure 5](#fig5){ref-type="fig"}B). When liposomes contained either bPI4P or bPS, FRET was not observed ([Figures 5](#fig5){ref-type="fig"}B and 5C). However, FRET was observed in the presence of both bPI4P and bPS, and the FRET signal was further increased by the addition of cholesterol ([Figures 5](#fig5){ref-type="fig"}B and 5C), suggesting that bPS and bPI4P are in close apposition to each other in the presence of cholesterol. Similarly, the co-distribution of unsaturated DOPS and bPI4P was enhanced in the presence of cholesterol ([Figure 5](#fig5){ref-type="fig"}D). Likewise, ergosterol increased the co-distribution of PO-PI4P with unsaturated POPS and DOPS ([Figure 5](#fig5){ref-type="fig"}E). Binding of the PI4P probe to liposomes was not significantly enhanced by the presence of cholesterol and DOPS ([Figures S5](#mmc1){ref-type="supplementary-material"}A and 5B). Likewise, membrane binding of the PS probe was not significantly enhanced by the presence of cholesterol and PI4P ([Figures S5](#mmc1){ref-type="supplementary-material"}C), consistent with a previous study ([@bib24]). Thus, the observed increases in FRET efficiencies between the PI4P and PS probes ([Figures 5](#fig5){ref-type="fig"}B and 5E) are not likely due to increased membrane recruitment of the lipid probes. Sterols may cause and/or enhance the co-distribution of unsaturated PS and PI4P *in vitro*. However, these experiments do not fully exclude sterol-induced effects on lipid probe binding affinities or membrane fluidity on FRET efficiencies.Figure 5Co-distribution of Unsaturated PS and PI4P in the Presence of Sterols *In Vitro*(A) The *in vitro* FRET assay to detect PI4P and PS co-distribution on liposomes. Corrected FRET (cFRET) was calculated as described in [STAR Methods](#sec4){ref-type="sec"}.(B) Emission spectrum of Venus-P4C (PI4P probe) and CFP-C2~Lact~ (PS probe) *in vitro*, as described in [STAR Methods](#sec4){ref-type="sec"}. The x and y axis indicate wavelength and intensity of emission fluorescence, respectively. Note that FRET signal was increased in the presence of both brain phosphatidylserine (bPS) and cholesterol (Chol). Asterisks indicate positions of emission maximum of CFP at 476 nm (^∗^) and FRET at 528 nm (^∗∗^).(C) FRET toward liposomes either lacking or containing 1 mol% bPI4P, bPS, and/or cholesterol (Chol) as indicated.(D) FRET toward 1 mol% bPI4P liposomes containing the indicated PS species either lacking or containing Chol.(E) FRET toward 1 mol% PO-PI4P liposomes containing the indicated PS species either lacking or containing ergosterol (Erg). Data represent mean ± SEM (n = 3).^∗∗∗^p \< 0.001. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

PM Targeting of the PIP5K Specificity Loop Depends on PI4P, PS, and Sterol {#sec2.6}
--------------------------------------------------------------------------

The substrate specificity and membrane targeting of PIP5Ks are determined by the specificity loop within their catalytic domains ([Figure 6](#fig6){ref-type="fig"}A) ([@bib17], [@bib27], [@bib36]). The specificity loop of PIP5K (5K~loop~) folds into an amphipathic helix (AH) upon membrane binding ([Figures 6](#fig6){ref-type="fig"}B and 6C) ([@bib38]). We checked if an amphipathic property of the 5K~loop~ is required for PIP5K function. The purified yPIP5K/Mss4 kinase domain showed PIP5K activity in the presence of both bPS and cholesterol, whereas the L722K/L729K mutant protein bearing mutations in the hydrophobic face showed low PIP5K activity ([Figure 6](#fig6){ref-type="fig"}D). These results suggest that an amphipathic property of the 5K~loop~ is critical for PIP5K activity. Moreover, basic residues on the opposite face of the 5K~loop~ were required, as a negatively charged mutant K720D/K721D did not display PIP5K activity ([Figure 6](#fig6){ref-type="fig"}D). We also investigated requirements for the amphipathic property of the 5K~loop~ *in vivo*. The L722K/L729K and K720D/K721D mutant forms neither localized to the PM ([Figure S6](#mmc1){ref-type="supplementary-material"}A) nor restored the growth defect of *mss4*^*ts*^ cells ([Figures S2](#mmc1){ref-type="supplementary-material"}B). On the other hand, a kinase dead mutant (K571A) lacking PIP5K activity ([Figure 6](#fig6){ref-type="fig"}D) localized to the PM ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Thus, an amphipathic property of the 5K~loop~ is required not only for PIP5K activity *in vitro* but also for PIP5K localization and function *in vivo*.Figure 6The PIP5K Specificity Loop Requires Osh Proteins, PS, and Sterols for PM Targeting(A) Crystal structure of zebrafish PIP5K (zPIP5K) ([@bib27]). The specificity loop region (5K~loop~: residues 380--403) was disordered in the crystal structure. The catalytic site (residue K236 in zPIP5K corresponding to K571 in yeast PIP5K) is shown in magenta.(B) The amphipathic properties of the specificity loop of zPIP5K and yeast PIP5K (yPIP5K). Helical wheel representations were drawn using HeliQuest. Hydrophobic residues are shown in yellow, arginine and lysine in dark blue, histidine in light blue, serine in purple, and glutamate and aspartate in red. Substitutions disrupting charge and the amphipathic property of the specificity loop of yPIP5K are shown in the bottom row (K720D/K721D and L722K/L729K, respectively). Z indicates net charge and arrows in helical wheels correspond to the hydrophobic moment.(C) The amphipathic character of the specificity loop of zPIP5K (5K~loop~) using PEP-FOLD 3 and PyMOL.(D) Real-time PIP5K assays using 200 nM wild-type or mutant forms of the yeast PIP5K domain (yPIP5K). K571A is a kinase-dead form of yPIP5K. Data represent mean values (n ≥ 3; SEM \< 0.61 × 10^3^).(E) Design of the 5K~loop~-GCC-GFP FLARE.(F) Localization of 5K~loop~-GCC-GFP and GFP-P4C (PI4P FLARE) in wild-type and *osh1-7*Δ/*osh4*^*ts*^ cells cultured at 38°C for 2 h.(G) 5K~loop~-GCC-GFP PM signal in wild-type and *osh1-7*Δ/*osh4*^*ts*^ cells. Data represent mean ± SD (n ≥ 46 cells).(H) Localization of 5K~loop~-GCC-GFP in the sterol auxotroph *GL7* strain cultured with or without 10 μg/ml ergosterol (Erg).(I) 5K~loop~-GCC-GFP PM signal in *GL7* cells. Data represent mean ± SD (n ≥ 36 cells).(J) Localization of 5K~loop~-GCC-GFP in wild-type and *cho1*Δ mutant cells supplemented with 1 mM ethanolamine.(K) 5K~loop~-GCC-GFP PM signal in wild-type and *cho1*Δ cells. Data represent mean ± SD (n ≥ 69 cells). Scale bars, 4 μm.^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

To further examine 5K~loop~ PM targeting, the specificity loop of zPIP5K (zPIP5Kγ aa 380--403) was fused to a GFP-tagged coiled-coil domain (5K~loop~-GCC-GFP; [Figure 6](#fig6){ref-type="fig"}E) to enhance its membrane affinity ([@bib26]). In wild-type yeast cells, 5K~loop~-GCC-GFP localized to the PM ([Figure 6](#fig6){ref-type="fig"}F). In contrast, the 5K~loop~-GCC-GFP mislocalized from the PM to intracellular compartments in *osh1-7*Δ*/osh4*^*ts*^ cells ([Figures 6](#fig6){ref-type="fig"}F and 6G). Consistent with this, PM targeting of the yeast PIP5K Mss4 was significantly reduced in *osh1-7*Δ*/osh4*^*ts*^ mutant cells at the restrictive temperature ([Figure S6](#mmc1){ref-type="supplementary-material"}B). We, therefore, examined lipid requirements for 5K~loop~ PM targeting. We first confirmed if the 5K~loop~ depended on PI4P by using *pik1*^*ts*^, *stt4*^*ts*^, and *pik1*^*ts*^*/stt4*^*ts*^ double mutant cells impaired in the major PI 4-kinase activities in yeast ([@bib3]). The PM localization of 5K~loop~-GCC-GFP was partially reduced in *pik1*^*ts*^ and *stt4*^*ts*^ single mutants and nearly disappeared in *pik1*^*ts*^*/stt4*^*ts*^ double mutant cells ([Figure S6](#mmc1){ref-type="supplementary-material"}C). In contrast, PM localization of 5K~loop~-GCC-GFP was not reduced in *mss4*^*ts*^ mutant cells impaired in PI(4,5)P~2~ synthesis ([Figure S6](#mmc1){ref-type="supplementary-material"}D), indicating that 5K~loop~-GCC-GFP mislocalization is not caused by reductions in PI(4,5)P~2~. Importantly, the PI4P FLARE GFP-P4C accumulated at the PM in *osh1-7*Δ*/osh4*^*ts*^ cells ([Figure 6](#fig6){ref-type="fig"}F). Thus, although PI4P is required for 5K~loop~ PM targeting, PI4P alone is not sufficient. We then analyzed whether sterol is required for 5K~loop~-GCC-GFP PM localization by using the auxotrophic sterol strain *GL7* that also has been shown to be impaired in PI(4,5)P~2~ synthesis ([@bib13]). Localization of 5K~loop~-GCC-GFP to the PM in *GL7* mutant cells depended on exogenous ergosterol ([Figures 6](#fig6){ref-type="fig"}H and 6I). In addition to sterol dependence, the PM targeting of 5K~loop~-GCC-GFP was significantly reduced in *cho1*Δ mutant cells deficient in PS synthesis ([Figures 6](#fig6){ref-type="fig"}J and 6K). Thus, PM localization of the 5K~loop~ depended on PI4P, PS, and sterol *in vivo*. Our *in vitro* assays indicated that unsaturated PI4P and PS promote PIP5K membrane binding and activity ([Figure 3](#fig3){ref-type="fig"}). To investigate a requirement for lipid unsaturation in 5K~loop~ PM targeting and PI(4,5)P~2~ synthesis *in vivo*, we analyzed *ole1*Δ mutant cells lacking the major fatty acid desaturase activity in yeast ([@bib46]). Upon removal of exogenous unsaturated fatty acid from the medium, both GFP-2xPH~PLCδ~ and 5K~loop~-GCC-GFP displayed reduced PM localization in *ole1*Δ mutant cells ([Figures S6](#mmc1){ref-type="supplementary-material"}E and S6F). Altogether, our results suggest that the 5K~loop~ recognizes unsaturated PI4P and PS membrane environments stabilized by sterol *in vivo*.

PIP5K Specificity Loop Shows Specific Interactions in Bilayers {#sec2.7}
--------------------------------------------------------------

To study the molecular interactions of the 5K~loop~ with bilayers, we ran extensive MD simulations in atomistic resolution. We modeled the zPIP5K peptide (zPIP5Kγ aa 380--403) as an α-helix and inserted it onto a bilayer composed of 69 mol% POPC, 10 mol% DOPS, 1 mol% bPI4P (18:0/20:4), and 20 mol% cholesterol (the composition activating zPIP5K). After solvation and equilibration, we simulated three replicas of the system for a cumulative time of 24 μs in the atomistic CHARMM36m representation ([@bib28]). During all simulations the 5K~loop~ remained stably inserted in the bilayer, displaying only a partial unfolding of few residues at the C terminus ([Figures 7](#fig7){ref-type="fig"}A--7C). The 5K~loop~ equilibrates relatively deep in the membrane, with the residues of its hydrophobic interface inserted in the hydrophobic core of the bilayer ([Figures 7](#fig7){ref-type="fig"}A--7C).Figure 7Molecular View of the PIP5K Specificity Loop Embedded in a Lipid Bilayer(A--C) The specificity loop of PIP5K (5K~loop~) embedded into a model membrane bilayer in atomistic molecular dynamics simulations. The 5K~loop~ is shown as ribbon (orange) with hydrophobic, polar, acidic, and basic amino acids represented as sticks in white, green, red, and blue, respectively. The surfaces of lipids and sterols are shown for POPC (gray), DOPS (magenta), cholesterol (cyan), and bPI4P (yellow). The figure shows an area of the membrane leaflet of approximately 4 × 4 nm (A). Cross sectional views of the 5K~loop~ embedded in the model membrane bilayer (B and C). Water and ions outside the membrane are omitted for clarity.(D--G) Lipid localization. Time-averaged positions of the phosphate moieties of the phospholipids POPC (D), DOPS (E), and PI4P (G) or oxygen atoms in cholesterol (Chol, F) from all-atom molecular dynamics simulations of a model membrane bilayer. Colors indicate the localization probability of different lipids over the course of the whole 10-μs trajectory. The membrane leaflet (cytoplasmic) with the 5K~loop~ embedded is shown in the left panels; the opposing leaflet (extracellular) is shown on the right. Scale bars, 2.5 nm.(H--J) Atomistic views of the bPI4P molecule interacting with pocket \#1 of the 5K~loop~ with a cholesterol molecule on the other side as shown in [Figure 7](#fig7){ref-type="fig"}B (H); 90° orientation (I); 180° orientation (J). The two phosphate moieties of bPI4P interact with four basic residues of the amphipathic helix (R384, K387, K388, and H391). The cholesterol hydrocarbon chain wedges between the acyl chains of the polyunsaturated PI4P. The amphipathic helix is visualized as a ribbon (orange) and acidic and basic residues as sticks in green. Positively charged nitrogen atoms and negatively charged oxygen atoms are shown as spheres, colored blue and red, respectively.See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

To gain a systematic view on how the different lipid species interact with the 5K~loop~, we calculated their localization probabilities over the cumulated simulation time. POPC does not form specific contacts with the 5K~loop~, and despite its abundance in the model bilayer, its localization is marginally affected by the presence of the helix (compare the two leaflets in [Figure 7](#fig7){ref-type="fig"}D). By contrast, DOPS molecules form contacts with the 5K~loop~ by electrostatic interactions ([Figure 7](#fig7){ref-type="fig"}E), and cholesterol transiently associates with the 5K~loop~ ([Figure 7](#fig7){ref-type="fig"}F). Given the low molar concentration, only a few bPI4P molecules are present in the bilayer we simulated. However, in all our simulations, a bPI4P quickly associates to the 5K~loop~ forming a contact that remains stable for the rest of the simulations, mostly due to its net charge. This is reflected in the probability maps ([Figure 7](#fig7){ref-type="fig"}G) showing that bPI4P strongly interacts with two sites along the 5K~loop~.

Visual inspection of the trajectories reveals a rich set of interactions between the 5K~loop~ and the different lipid species. Cholesterol molecules reversibly associate to the 5K~loop~, filling the packing defect created by the insertion of the helix and interacting with aromatic residues (e.g., W393; [Figure 7](#fig7){ref-type="fig"}B). Interestingly, the cholesterol hydrocarbon chain also wedges between the acyl chains of the polyunsaturated PI4P stably associated with the 5K~loop~ ([Figures 7](#fig7){ref-type="fig"}B, 7H, and 7J). Electrostatic interactions drive the formation of contacts between the charged headgroups of DOPS and bPI4P, and the positively charged residues located on the hydrophilic face of the 5K~loop~. DOPS and bPI4P can occupy distinct pockets along opposing sides of the 5K~loop~ at the same time ([Figures 7](#fig7){ref-type="fig"}B, 7E, and 7G). It is important to note, however, that PI4P and DOPS are almost never found on the same side of the 5K~loop~. This is due to the highly charged PI4P headgroup occupying all electrostatic interactions on one side of the 5K~loop~. This observation is in line with the localization plots of the densities of each lipid on opposing sides ([Figures 7](#fig7){ref-type="fig"}E and G). PI4P is situated very close to the 5K~loop~, whereas DOPS is relatively far away. Nevertheless, DOPS interacts by its headgroup with residues K387 and K394 and also pushes its hydrophobic tails under the 5K~loop~, where cholesterol is wedged in ([Figure 7](#fig7){ref-type="fig"}B). bPI4P forms intimate interactions with the 5K~loop~, almost wrapping around it, maximizing the contact both with its headgroup and its polyunsaturated acyl chain ([Figures 7](#fig7){ref-type="fig"}C, 7H, and 7J). Indeed, bPI4P can interact with the 5K~loop~ by its glycerol backbone, the 1-phosphate moiety between the backbone and inositol, and the hydroxyl-groups and 4-phosphate moiety on the inositol ring ([Figures 7](#fig7){ref-type="fig"}H--7J and [S7](#mmc1){ref-type="supplementary-material"}A--S7F). The latter enables the headgroup of bPI4P to bridge over several lipids and interact with the 5K~loop~ even if the lipid tails are relatively far away ([Figures S7](#mmc1){ref-type="supplementary-material"}D--S7F). These observations suggest that association of bPI4P and the 5K~loop~ should be described in terms of a dynamic network of electrostatic interactions that can be mediated by other lipid molecules.

Discussion {#sec3}
==========

Our findings show that Osh-mediated membrane lipid dynamics and ER-PM contacts promote PIP5K activity at the PM ([Figure S7](#mmc1){ref-type="supplementary-material"}G). Remarkably, our data indicate that only a small pool of PI4P synthesized in the cell is used as a substrate for PI(4,5)P~2~ synthesis. PI4P appears to be largely consumed during Osh-mediated lipid exchange reactions ([Figures 1](#fig1){ref-type="fig"}, [S1](#mmc1){ref-type="supplementary-material"}, and [4](#fig4){ref-type="fig"}). In this manner, newly synthesized PS and sterol lipids may be transported from the ER to the PM by Osh proteins in exchange for PI4P ([Figure S7](#mmc1){ref-type="supplementary-material"}G). The Osh proteins may then transfer PI4P to the ER ([@bib2]) or directly present PI4P to the Sac1 PI4P phosphatase at ER-PM contacts ([@bib54]). Both modes of Sac1 activity (in *cis* and in *trans*) would promote continued rounds of lipid transfer by the Osh proteins, as both mechanisms would release PI4P bound to Osh proteins. Thus, PI4P serves two vital functions in the cell. It is the substrate for PIP5K and it is used as a "currency" for ORP/Osh-mediated lipid exchange that stimulates PIP5K activity. Importantly, our data indicate that PI4P alone is not sufficient for PIP5K activity. However, once PS and sterol lipids reach sufficient levels, PI4P metabolism switches from PI4P exchange and hydrolysis by the Osh and Sac1 system to PI(4,5)P~2~ synthesis by PIP5K ([Figure S7](#mmc1){ref-type="supplementary-material"}G). This has two significant implications. First, PI4P extraction by Osh proteins will decrease upon PS and sterol delivery because of competition between PI4P and PS or sterol for the Osh proteins ([@bib44]). Second, PI4P, PS, and sterol synergistically promote PIP5K targeting and activity. Thus, non-vesicular lipid dynamics taking place at ER-PM contacts may promote the formation of PIP5K assemblies that ultimately drive vesicular trafficking events in adjacent ER-free PM zones.

ORP and Osh proteins may also exchange PI4P for PS and sterol at late Golgi and secretory compartments ([@bib2]) ([Figure S7](#mmc1){ref-type="supplementary-material"}G). This may promote secretory vesicle maturation and allow rapid conversion of PI4P to PI(4,5)P~2~ immediately prior to or following vesicle fusion with the PM. Alternatively, PI4P extracted from late Golgi compartments and other organelles may be directly transferred to the PM by Osh proteins. Both of these mechanisms could explain the involvement of Golgi PI4P pools in 5K~loop~ PM targeting and PI(4,5)P~2~ synthesis ([Figure S6](#mmc1){ref-type="supplementary-material"}) ([@bib3]) and why cells depleted of ER-PM contacts are viable ([@bib40]). Osh proteins also control sterol distribution within the PM ([@bib19]). Accordingly, ORP/Osh proteins might move lipids within the PM resulting in PIP5K activation.

Our study confirms key roles for the ORP/Osh proteins and ER-PM contacts in PM identity. Both are required for enrichment of PS in the cytoplasmic leaflet of the PM ([Figures 1](#fig1){ref-type="fig"} and [S1](#mmc1){ref-type="supplementary-material"}), consistent with previous reports ([@bib10], [@bib44]). Our findings unexpectedly suggest that the ORP/Osh proteins also create heterogeneous PM environments and, thus, transient unconventional lipid interactions at the nanoscale level. Numerous studies have described physical interactions between saturated lipids and sterols. Yet, less attention has been paid to the effect of sterols on unsaturated lipids, in spite of the fact that PS and PI4P are key components of the inner leaflet of the PM ([@bib4], [@bib58]) and most of them have unsaturated fatty acids ([Figure 4](#fig4){ref-type="fig"}). Our analyses suggest that unsaturated PI4P and PS co-distribution might be modulated by sterols ([Figure 5](#fig5){ref-type="fig"}). Unsaturated fatty acids are incorporated into the *sn-2* position in most phosphoinositides (PIPs) ([@bib21]), but unsaturated lipids are not efficiently incorporated into sterol-containing liquid-ordered domain. One possible explanation is that unsaturated lipids are condensed by their repulsive interaction with sterols ([@bib35]). Alternatively, our MD simulations indicate that cholesterol interacts with the acyl chains of polyunsaturated PI4P stably associated with the PIP5K specificity loop and fills the packing defect created by insertion of the peptide helix ([Figure 7](#fig7){ref-type="fig"}). Additional interactions may also provide important contributions. For example, PS retains cholesterol in the inner leaflet of the PM and cholesterol, in turn, limits electrostatic repulsion between anionic PS molecules ([@bib24], [@bib39]). This may explain why inactivation of Osh4, shown to transfer sterol lipids *in vitro*, results in decreased PS levels at the PM ([Figures 1](#fig1){ref-type="fig"} and [4](#fig4){ref-type="fig"}). The ionization state of PIPs, dependent on neighboring lipids and ionic strength, may also govern PIP segregation patterns ([@bib57]). Thus multiple factors likely account for the complex behavior of unsaturated phospholipids and sterols in membranes.

Our *in vivo* imaging, *in vitro* assays, and simulation analyses suggest that the conserved PIP5K specificity loop forms an AH that prefers a membrane environment containing unsaturated anionic lipids and sterols. Given that another anionic lipid, PA, also stimulates PIP5K ([@bib50]), PA might interact with the PIP5K AH similarly to PS. Interestingly, the hydrophobic face of the PIP5K AH contains bulky aromatic residues, similar to other AH sensors that preferentially insert into membrane regions with lipid packing-order defects formed by acyl chain unsaturation. This design may allow PIP5K to recognize unsaturated PI4P species that cluster in intermittent disordered regions of the PM. Given that yeast PO-PI4P was an effective substrate for PIP5K ([Figure S3](#mmc1){ref-type="supplementary-material"}), yeast PI4P might induce lipid-packing defects as much as mammalian PI4P. It is remarkable that the PIP5K AH targets to the PM rather than the highly disordered ER. Accordingly, PM targeting of the PIP5K AH is specified by basic residues within the AH that bind PI4P and PS (and PA) in the cytoplasmic leaflet of the PM and is further stabilized by interactions with sterols ([Figure 7](#fig7){ref-type="fig"}). Thus, the PIP5K AH is endowed with distinctive chemical and physical properties, compared to previously described AH membrane sensors ([@bib7], [@bib12], [@bib25]), allowing it to detect a unique PM environment containing PI4P, PS, and sterol. Although PIP5K AH targeting to the PM depended on both PS and PI4P, our analyses indicate increased binding affinity for PI4P over PS. This suggests an order of events for PIP5K targeting and activity. The ORP/Osh proteins may form a PM environment enriched in unsaturated PS stabilized by sterols that initially recruits PIP5K ([Figure S7](#mmc1){ref-type="supplementary-material"}G).

The human ORP5 and ORP8 proteins transfer unsaturated PS species ([@bib10]), suggesting they may be involved in PI(4,5)P~2~ regulation. In turn, PI(4,5)P~2~ controls ORP5 and ORP8 PM localization ([@bib20], [@bib52]), indicating cross-regulation of PS and PI(4,5)P~2~ homeostasis. Intriguingly, ORP5 and ORP8 knock down results in increased PI(4,5)P~2~ levels ([@bib20], [@bib52]). But PI4P is increased and PS levels are maintained to some extent upon ORP5 and ORP8 depletion, implying that other ORP isoforms or other lipid transfer proteins may be induced under these conditions. As such, future studies are likely to reveal key roles for additional lipid transfer proteins in PM lipid heterogeneity and organization.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial and Virus Strains**BL21 (DE3)New England BioLabsC2527IRosetta (DE3) pLysSMerck70956**Chemicals, Peptides, and Recombinant Proteins**EthanolamineACROS Organics149580010Tween 80SIGMA-ALDRICHP1754(Trimethylsilyl)diazomethane solution 2.0 M in hexanesSIGMA-ALDRICH362832Formic acid eluent additive for LC-MSSIGMA-ALDRICH56302ACQUITY UPLC Protein BEH C4 Column, 300Å, 1.7 μm, 1 mm X 100 mmWaters186005590Yeast nitrogen base without amino acids, ammonium sulfate and inositolFORMEDIUMCYN3810Casamino AcidsFORMEDIUMCAS01Myo-\[2-H^3^\]-inositolPerkinElmerNET114A005MCPerchloric acidACROS Organics223312500Glass beadsSIGMAG127740% methylamineSIGMA-ALDRICH4264661-ButanolACROS Organics107690025Diethyl-etherACROS Organics176830010Ethyl formateACROS Organics150675000Partisphere 5 μm SAX columnHichrome4621-1505Ammonium phosphate, dibasicACROS Organics201820025Phosphoric acidACROS Organics389020025Ultima-Flo AP scintillation fluidPerkinElmer6013599Malachite GreenSIGMA-ALDRICH38800Ammonium molybdateSIGMA-ALDRICH277908Sulfuric acidSIGMA-ALDRICH339741Complete EDTA-free protease inhibitorThermo Fisher ScientificA32955Dithiothreitol (DTT)Thermo Fisher ScientificR0861AEBSF Protease InhibitorThermo Fisher Scientific78431Glutathione Sepharose 4BGE Healthcare17-0756-01PreScission proteaseGE Healthcare270843Ni-NTA AgaroseQIAGEN1018244ImidazoleSIGMA ALDRICHI202IANBD-amideInvitrogenD2004L-Cysteine HydrochlorideSIGMAC7477NitroPure^TM^, Nitrocellulose Transfer Membrane, 0.45 μmGVS1212602SuperSignal^TM^ West Pico Chemiluminescent SubstrateThermo Scientific10481755Purified Mouse Anti-6xHisBD Biosciences552565DP-PI4P (16:0/16:0)CellSignals912ErgosterolUnited States Biological275432Brain PI4P (L-α-phosphatidylinositol-4-phosphate)Avanti Polar Lipids840045XBrain PI(4,5)P~2~ (L-α-phosphatidylinositol-4,5-bisphosphate)Avanti Polar Lipids840046XEgg PC (L-α-phosphatidylcholine)Avanti Polar Lipids840051Brain PS (L-α-phosphatidyserine)Avanti Polar Lipids840032POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine)Avanti Polar Lipids850457CholesterolAvanti Polar Lipids700000POleic acidSigma-AldrichO1008Egg PA (L-α-phosphatidic acid) (Egg, Chicken)Avanti Polar Lipids840101Liver PI (L-α-phosphatidylinositol) (Liver, Bovine)Avanti Polar Lipids840042POPE (2-Oleoyl-1-palmitoyl-*sn*-glycero-3-phosphoethanolamine)SigmaO199118:1 Dansyl PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(5-dimethylamino-1-naphthalenesulfonyl)Avanti Polar Lipids810330PO-PI4P (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate))Avanti Polar Lipids850157PDPPS (1,2-dipalmitoyl-sn-glycero-3-\[phospho-L-serine\])Avanti Polar Lipids840037POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-\[phospho-L-serine\])Avanti Polar Lipids840034DOPS (1,2-dioleoyl-sn-glycero-3-\[phospho-L-serine\])Avanti Polar Lipids84003517:0-20:4 PI(4)P (1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) (ammonium salt))Avanti Polar LipidsLM190117:0-20:4 PI(4,5)P~2~ (1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-4',5′-bisphosphate) (ammonium salt))Avanti Polar LipidsLM190417:0-20:4 PI(3,4,5)P~3~ (1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3′,4',5′-trisphosphate) (ammonium salt))Avanti Polar LipidsLM190617:0-20:4 PI (1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt))Avanti Polar LipidsLM150217:0-20:4 PS (1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-L-serine (ammonium salt))Avanti Polar LipidsLM1302Zirconia beads 5.0 mmTOMYZB-50Mini-extruder SetAvanti Polar Lipids610000PC Membranes 0.1 μmAvanti Polar Lipids610005PC Membranes 0.4 μmAvanti Polar Lipids610007PC Membranes 1.00 μmAvanti Polar Lipids610010Filter SupportsAvanti Polar Lipids610014Slide-A-Lyzer^TM^ Dialysis Cassettes, 3.5K MWCOThermo Fisher Scientific66330Propidium iodideInvitrogenP3566**Deposited Data**Raw imaging dataThis studyMendeley Data: <https://doi.org/10.17632/x96sprmwrg.1>**Critical Commercial Assays**ADP-Glo^TM^ Kinase AssayPromegaV6930**Experimental Models: Organisms/Strains**SEY6210 \[*MATα leu2-3,112 ura3-52 his3Δ200 trp1-Δ901 lys2-801 suc2Δ9*\]PMID: 3062374N/ASEY6210.1 \[*MAT****a****leu2-3,112 ura3-52 his3Δ200 trp1-Δ901 lys2-801 suc2Δ9*\]PMID: 3062374N/ACBY886 (*osh1-7*Δ*/osh4*^*ts*^) \[*SEY6210 osh1*Δ*::kan-MX4 osh2*Δ*::kan-MX4 osh3*Δ*::LYS2 osh4*Δ*::HIS3 osh5*Δ*::LEU2　osh6*Δ*::LEU2 osh7*Δ*::HIS3 (osh4-1, URA3*)\][@bib5]N/A*ANDY198* (Δtether) \[*SEY6210.1 ist2*Δ*::HISMX6 scs2*Δ*::TRP1 scs22*Δ*::HISMX6 tcb1*Δ*::KANMX6 tcb2*Δ*::KANMX6 tcb3*Δ*::HISMX6*\][@bib40]N/AAAY104 (*pik1*^*ts*^) \[*SEY6210 pik1*Δ*::HIS3 carrying* pRS314*pik1-83* (*TRP1 CEN6 pik1-83)*\][@bib3]N/AAAY102 (*stt4*^*ts*^) \[*SEY6210 stt4*Δ*::HIS3* carrying pRS415*stt4-4* (*LEU2 CEN6 stt4-4*)\][@bib3]N/AAAY105 (*pik1*^*ts*^*/stt4*^*ts*^) \[*SEY6210 stt4*Δ*::HIS3 pik1*Δ*::HIS3* carrying pRS415*stt4-4* (*LEU2 CEN6 stt4-4*) and pRS314*pik1-83* (*TRP1 CEN6 pik1-83*)\][@bib3]N/AAAY202 (*mss4*^*ts*^) \[SEY6210 *mss4*Δ*::HIS3MX6* carrying pYCplac111 *mss4-102 (LEU2 CEN6 mss4-102)*\][https://doi.org/10.1091/mbc.01-10-0476](10.1091/mbc.01-10-0476){#intref0015}N/AW303-1A \[*MATα leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15*\]PMID: 2645056N/A*cho1*Δ \[*W303-1A cho1*Δ*::URA3*\][https://doi.org/10.1021/bi300086c](10.1021/bi300086c){#intref0020}N/AYTN1 \[*W303-1A ADE2::URA3*\]This studyN/AYTN3 \[*W303-1A cho1*Δ*::URA3 ADE2::URA3*\]This studyN/A*GL7* \[*X2180****a****gal2 erg12-1 hem3-6*\]PMID: 323256N/AYTN39 \[*X2180****a****gal2 erg12-1 hem3-6 ura3*Δ:: *KANMX6*\]This studyN/A*ole1*Δ \[*BY4741 ole1*Δ*::CgHIS3*\][https://doi.org/10.1242/bio.022053](10.1242/bio.022053){#intref0025}N/ARecombinant DNApRS424-*P*^*PRC1*^-GFP-2xPH~PLCδ~This studyN/ApRS415-*P*^*GPD*^-mCherry-2xPH~PLCδ~[https://doi.org/10.1038/emboj.2012.127](10.1038/emboj.2012.127){#intref0030}N/ApRS426-*P*^*PRC1*^-GFP-2xPH~PLCδ~[https://doi.org/10.1091/mbc.01-10-0476](10.1091/mbc.01-10-0476){#intref0035}N/ApRS314-*P*^*GPD*^-GFP-C2~Lact~[@bib58]N/ApRS416-*P*^*GPD*^-GFP-C2~Lact~[@bib58]N/ApRS414-*P*^*GPD*^-GFP-P4C~SidC~This studyN/ApRS416-*P*^*GPD*^-GFP-P4C~SidC~[https://doi.org/10.1371/journal.ppat.1004965](10.1371/journal.ppat.1004965){#intref0040}N/ApEGFP-N1:GCC~GMAP210(39-377aa)~[@bib26]N/ApRS424-*P*^*GPD*^-5K~loop~-GCC~GMAP210~-GFPThis studyN/ApRS426-*P*^*GPD*^-5K~loop~-GCC~GMAP210~-GFPThis studyN/ApET21b+: *zPIP5K1Aα*~(49-431aa)~[@bib27]N/ApRS416-*P*^*GPD*^-*zPIP5K1Aα*~(49-431aa)~This studyN/ApRS414-*P*^*MSS4*^-*MSS4*-GFP[https://doi.org/10.1038/emboj.2012.127](10.1038/emboj.2012.127){#intref0045}N/ApRS416-*P*^*MSS4*^-*MSS4*-GFP[https://doi.org/10.1038/emboj.2012.127](10.1038/emboj.2012.127){#intref0050}N/ApRS416-*P*^*MSS4*^-*mss4* K571A-GFPThis studyN/ApRS416-*P*^*MSS4*^-*mss4* K720D/K721D-GFPThis studyN/ApRS416-*P*^*MSS4*^-*mss4* L722K/L729K-GFPThis studyN/ApRS414-*P*^*PIL1*^-*PIL1*-GFP[@bib32]N/ApRS314-*P*^*OSH4*^-*OSH4*[@bib5]N/ApRS314-*P*^*OSH4*^-*osh4* G183D (*ts* mutant)[@bib5]N/ApRS314-*P*^*OSH4*^-*osh4* H143A/H144AThis studyN/ApRS314-*P*^*OSH4*^-*osh4*Δ29This studyN/ApRS414-*P*^*GPD*^-*OSH6*This studyN/ApRS414-*P*^*GPD*^-*osh6* H157A/H158AThis studyN/ApGEX6P-1:PH~PLCδ~ V58CThis studyN/ApGEX6P-1:CFP-C2~Lact~This studyN/ApGEX6P-1:Venus-C2~Lact~This studyN/ApGEX6P-1:Venus-P4C~SidC~This studyN/ApGEX6P-1:*MSS4*~(347-779aa)~-his~6~This studyN/ApGEX6P-1:*mss4*~(347-779aa)~ K571A-his~6~This studyN/ApGEX6P-1: *mss4*~(347-779aa)~ K720D/K721D-his~6~This studyN/ApGEX6P-1: *mss4*~(347-779aa)~ L722K/L729K-his~6~This studyN/A**Software and Algorithms**Fiji/ImageJFijiRRID: [SCR_002285](rridsoftware:SCR_002285){#intref0055}Adobe Photoshop CS6 extendedAdobeRRID: [SCR_014199](rridsoftware:SCR_014199){#intref0060}GraphPad Prism 6GraphPad SoftwareRRID: [SCR_002798](rridsoftware:SCR_002798){#intref0065}RStudioRStudioRRID: [SCR_000432](rridsoftware:SCR_000432){#intref0070}HeliQuestCNRS<http://heliquest.ipmc.cnrs.fr/>PyMOLSchrodingerRRID: [SCR_000305](rridsoftware:SCR_000305){#intref0080}PEP-FOLD 3RPBS<http://bioserv.rpbs.univ-paris-diderot.fr/services/PEP-FOLD3/>VMDUniversity of Illinois<https://www.ks.uiuc.edu/Research/vmd/>[https://doi.org/10.1016/0263-7855(96)00018-5](10.1016/0263-7855(96)00018-5){#interref0010}GROMACSEuropean Research CouncilRRID: [SCR_014565](rridsoftware:SCR_014565){#intref0095}[https://doi.org/10.1016/j.softx.2015.06.001](10.1016/j.softx.2015.06.001){#intref0100})MDAnalysis[https://doi.org/10.25080/majora-629e541a-00e](10.25080/majora-629e541a-00e){#intref0105}<https://www.mdanalysis.org/>[https://doi.org/10.1002/jcc.21787](10.1002/jcc.21787){#intref0115}NumPy<http://SciPy.org>RRID: [SCR_008633](rridsoftware:SCR_008633){#intref0125}[https://doi.org/10.1109/MCSE.2011.37](10.1109/MCSE.2011.37){#interref0015}SciPy<http://SciPy.org>RRID: [SCR_008058](rridsoftware:SCR_008058){#intref0135}IPython<http://ipython.org>RRID: [SCR_001658](rridsoftware:SCR_001658){#intref0145}[https://doi.org/10.1109/MCSE.2007.53](10.1109/MCSE.2007.53){#interref0020}Matplotlib<http://SciPy.org>RRID: [SCR_008624](rridsoftware:SCR_008624){#intref0155}[https://doi.org/10.1109/MCSE.2007.55](10.1109/MCSE.2007.55){#interref0025}UCSF CHIMERAUCSF\
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Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Christopher J. Stefan (<c.stefan@ucl.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Yeast {#sec4.3.1}

Descriptions of *Saccharomyces cerevisiae* strains used in this study are in the [Key Resources Table](#sec4.1){ref-type="sec"}. Standard techniques were used for yeast growth. For *cho1*Δ cells, the medium was supplemented with 1 mM ethanolamine. For the *GL7* strain (provided by Dr. W. David Nes, Texas Tech Univ.), 2 mg/ml ergosterol solubilized in a Tween 80/ethanol solution (1:4, w/w) was added to the medium as a 0.5% solution for a final concentration of 10 μg/ml. The *URA3* gene in the *GL7* strain was deleted by homologous recombination. For *ole1*Δ cells (provided by Dr. Takeshi Noda, Osaka Univ.), 0.5% casamino acids were added to support growth of the *ole1*Δ mutant cells in synthetic defined medium. Oleic acid at a final concentration of 1 mM and 1% (v/v) Triton X-100 were also added to the culture medium.

Method Details {#sec4.4}
--------------

### Plasmids {#sec4.4.1}

Descriptions of plasmids used in this study are in the [Key Resources Table](#sec4.1){ref-type="sec"}. DNA sequences encoding yPIP5K/Mss4 fragment (aa 347-779, NP_010494) were amplified by PCR and subcloned into pGEX-6P-1 vector together with His-Tag. yPIP5K K571A, K720D/K721D, and L722K/L729K were generated by inverse PCR. C2~Lact~ and P4C cDNAs were amplified by PCR and subcloned into pGEX-6P-1 vector together with CFP and/or Venus. cDNA encoding zPIP5K (aa 49-431, NP_001018438) (provided by Dr. Ya Ha, Yale School of Medicine) was subcloned into pRS416 plasmid. zPIP5K fragment (aa 380-403) fused to GMAP210 coiled-coil region (aa 39-377) (provided by Dr. Bruno Antonny, CNRS Université de Nice Sophia Antipolis) was cloned into pRS424 or pRS426 plasmid together with EGFP. Osh4 wild-type, G183D (*ts* mutant), Δ29, and H143A/H144A cDNAs were subcloned into pRS314 plasmid. Osh6 wild-type and H157A/H158A cDNAs (provided by Dr. Guillaume Drin, CNRS Université de Nice Sophia Antipolis) were subcloned into the plasmid pRS414. GFP-P4C and 2xPH~PLCδ~ were subcloned into pRS414 or pRS424, respectively.

### Fluorescence Microscopy {#sec4.4.2}

Images were obtained with a 100 × CFI Plan Apochromat VC oil-immersion objective lens (1.4 NA), using a Perkin-Elmer Ultraview VOX spinning disk confocal microscope that consists of a Nikon TiE inverted stand attached to Yokogawa CSU-X1 spinning unit and a Hamamatsu C9100-13 EMCCD camera with a pixel size of 16 μm. All images were collected as square images with 512 × 512 pixels. For the final output, images were processed using Fiji/ImageJ and Adobe Photoshop CS6 extended software. Plasma membrane (PM) relative fluorescence (relative F~PM~) was quantified as described below. Briefly, single channel images were created by splitting channels. Single cell images were randomly chosen from the single channel images, duplicated and saved. Three lines (crossing over, inside and outside a cell) were drawn on the single cell images, added to ROI manager, and analyzed by 'Multi Plot' module in Fiji/ImageJ to obtain fluorescence intensity profiles. These values, related to the intensity values for each pixel, were imported into Excel. We then calculated the average values of fluorescence intensity profiles on drawn lines inside and outside a cell, and expressed as F~in~ and F~out~, respectively. The specific cytosolic signal (F~cyto~) was calculated by subtracting F~out~ from F~in~. In order to obtain PM fluorescence intensity (F~PM~), the two outer cellular intensity peaks were found on the line crossing over a cell. The average value of intensity of those two peaks, one pixel in front and behind peaks was calculated (F~cross~), and then subtracted F~out~ from F~cross~. F~PM~ was divided by F~cyto~ to calculate relative F~PM~. Taken together, PM relative fluorescence was calculated by using this equation: relative F~PM~ = F~PM~/F~cyto~ = (F~cross~-F~out~)/(F~in~-F~out~). Finding peaks in intensity profiles and calculations were automatically processed with an Excel VBA macro.

### Analysis of ^3^H-labeled Inositol Phosphates by HPLC {#sec4.4.3}

PIPs levels were analyzed as previously described ([@bib54]). Briefly, 5 OD~600~ units of cells cultured in YND media were washed by media lacking inositol and pre-incubated at 26°C or 38°C for 15 min. The cells were labeled with 50 μCi of myo-\[2-H^3^\]-inositol in media lacking inositol and further incubated for 1 hour. Then, the cells were lysed in 4.5% perchloric acid with glass beads to generate extracts. After washed by 0.1 M EDTA, the extracts were mixed with methylamine reagent (methanol/40% methylamine/water/1-butanol; 4.6:2.6:1.6:1.1 v/v) and incubated at 53°C for 1 h to deacylate phospholipids. Samples were dried in a vacuum chamber, washed with water, dried again, and resuspended in 300 μl water. Extraction reagent (1-butanol/ethl-ether/formic acid ethyl ester; 20:4:1 v/v) was added and \[^3^H\] glycerol-PIPs were separated into the aqueous phase by vortexing and centrifugation at 14,000 x *g* for 5 min. The extraction was repeated twice and the final aqueous phase was collected and dried. Dried pellets were resuspended in 260 μl water and separated on a Partisphere 5 μm SAX column attached to a PerkinElmer Series 200 HPLC system and a radiomatic 150TR detector using Ultima-Flo AP scintillation fluid. The HPLC and on-line detector were controlled with Total Chrome Navigator software. The data were analyzed using Total Chrome Navigator software.

### LC-MS/MS analysis of methylated PIPs and PS {#sec4.4.4}

20 OD~600~ units of cells were precipitated and washed with cold 4.5% perchloric acid. For phosphoinositide measurements, cells were resuspended in 500 μL 0.5 M HCl and disrupted with a 5.0 mm zirconia bead by vigorous shaking (1,500 rpm for 10 min) using Shake Master Neo (BMS, Tokyo, Japan). The homogenates were transferred to new tubes and centrifuged at 15,000 × *g* for 5 min. The pellets were resuspended in 170 μL water and 750 μL of CHCl~3~/MeOH/1 M HCl (2:1:0.1, v/v) and incubated for 5 min at room temperature. To each sample 725 μL of CHCl~3~ and 170 μL of 2 M HCl were added, followed by vortexing. After centrifugation at 1,500 × *g* for 5 min, the lower phase was collected and washed with 780 μL of pre-derivatization wash solution (the upper phase of CHCl~3~/MeOH/0.01 M HCl (2:1:0.75 v/v)). The lipid extracts were derivatized by adding 50 μL of 2 M TMS-diazomethane in hexane. The derivatization was carried out at room temperature for 10 min and was stopped by adding 6 μL of glacial acetic acid. The derivatized samples were washed twice with 700 μL of post-derivatization wash solution (the upper phase of CHCl~3~/MeOH/water (2:1:0.75 v/v)). After adding 100 μL of MeOH/H~2~O (9:1, v/v), the samples were dried under a stream of N~2~, dissolved in 80 μL of MeOH and sonicated briefly. After adding 20 μL of water, the samples were subjected to LC-ESI-MS/MS analysis. The LC-ESI-MS/MS analysis was performed on a Shimadzu Nexera ultra high performance liquid chromatography system coupled with a QTRAP 4500 hybrid triple quadrupole linear ion trap mass spectrometer. Chromatographic separation was performed on an Acquity UPLC C4 BEH column (100 mm × 1 mm, 1.7 μm; Waters) maintained at 40°C using mobile phase A (water containing 0.1% formate) and mobile phase B (acetonitrile containing 0.1% formate) in a gradient program (0--5 min: 45% B; 5--10 min: 45% B→100% B; 10-15 min: 100% B; 15--16 min: 100% B→45% B; 16-20: 45% B) with a flow rate of 0.1 mL/min. The instrument parameters for positive ion mode were as follows: curtain gas, 10 psi; collision gas, 7 arb. unit; ionspray voltage, 4500 V; temperature, 600°C; ion source gas 1, 30 psi; ion source gas 2, 50 psi; declustering potential, 121 V; entrance potential, 10 V; collision energy, 39 V; collision cell exit potential, 10 V. Methylated phosphoinositides and phosphatidylserine were identified and quantified by multiple reaction monitoring. For these measurements, an internal standard of 10 ng of 17:0-20:4 PIP was added to each sample.

### Quantitative shotgun lipid MS data acquisition, analysis, and post-processing {#sec4.4.5}

The glycerolipid compositions of wild-type, *osh1-7*Δ*/osh4*^*ts*^ and Δtether mutant cell extracts shown in the [Supplemental Information](#app1) were determined by mass spectrometry-based quantitative, shotgun lipidomics by Lipotype GmbH (Dresden, Germany) as described ([@bib16], [@bib33]). Total yeast cell lysate samples were diluted to 0.2 OD units using 155 mM ammonium bicarbonate in water to the total volume of 150 μl and were spiked with internal lipid standard mixture. Lipids were extracted using a two-step chloroform/methanol procedure with 750 μl volume of each organic phase step (chloroform:methanol, 15:1 and 2:1 respectively for the 1^st^ and the 2^nd^ step)([@bib16]). After extraction, the organic phase was transferred to an infusion plate and dried in a speed vacuum concentrator. 1^st^ step dry extract was re-suspended in 100 μl 7.5 mM ammonium acetate in chloroform/methanol/propanol (1:2:4, V:V:V) and 2^nd^ step dry extract in 100 μl 33% ethanol solution of methylamine in chloroform/methanol (0.003:5:1; V:V:V). All liquid handling steps were performed using Hamilton Robotics STARlet robotic platform with the Anti Droplet Control feature for organic solvents pipetting.

Samples were analyzed by direct infusion on a QExactive mass spectrometer (Thermo Scientific) equipped with a TriVersa NanoMate ion source (Advion Biosciences). Samples were analyzed in both positive and negative ion modes with a resolution of R~m/z =\ 200~ = 280000 for MS and R~m/z =\ 200~ = 17500 for MSMS experiments, in a single acquisition. MSMS was triggered by an inclusion list encompassing corresponding MS mass ranges scanned in 1 Da increments ([@bib55]). Both MS and MSMS data were combined to monitor EE, DAG and TAG ions as ammonium adducts; PC as an acetate adduct; and PA, PE, PG, PI and PS as deprotonated anions.

Data were analyzed with in-house developed lipid identification software based on LipidXplorer ([@bib23], [@bib22]). Data post-processing and normalization were performed using an in-house developed data management system. Only lipid identifications with a signal-to-noise ratio \> 5, and a signal intensity 5-fold higher than in corresponding blank samples were considered for further data analysis.

### Protein purification {#sec4.4.6}

*Eschericia coli* strains BL21 or Rosetta pLysS were used as a host cell line. Expression of recombinant protein was induced with 0.1-1 mM IPTG at 22°C or 37°C. The cell pellets were collected and resuspended in ice-cold homogenization buffer (50 mM Tris-HCl pH 6.8, 300 mM NaCl, 1 mM dithiothreitol (DTT), 0.1 mM AEBSF, and complete EDTA-free protease inhibitor). Cells were then disrupted by sonication in ice-cold homogenization buffer. The homogenized cells were centrifuged at 20,800 × *g* for 30 min to remove cell debris. GST recombinant proteins were purified with glutathione-Sepharose and cleaved from GST by using 0.1 U/μl PreScission protease. Untagged proteins were dialyzed with dialysis buffer (50 mM Tris-HCl pH 6.8, 150 mM NaCl, and 1 mM DTT) three times and then dialyzed with storage buffer (50 mM Tris-HCl pH 6.8, 150 mM NaCl, 2 mM DTT, and 50% glycerol) and stored at −80°C before analysis. For purification of His-tagged zPIP5K1Aα (49-431aa), 10 mM imidazole was additionally added to homogenization buffer to reduce non-specific binding. His-tagged recombinant proteins were purified with Ni-NTA Agarose, eluted by 80 mM and 160 mM imidazole and dialyzed as shown above.

### Preparation of NBD-PH~PLCδ~ Proteins {#sec4.4.7}

Rat PLCδ (NP_058731, 11-140 aa) cDNA (1x PH~PLCδ~) was amplified by PCR and subcloned into pGEX-6P-1. PH~PLCδ\ V58C~/pGEX6P-1 was prepared by introducing point mutations for NBD labeling. GST-PH~PLCδ\ V58C~ protein was purified as described above. After cleavage of GST tag, untagged PH~PLCδ\ V58C~ was dialyzed in TBS (50 mM Tris-HCl pH 6.8, and 150 mM NaCl) three times to remove DTT, and then labeled with a 10-fold excess of IANBD-amide. After overnight incubation at 4°C, the reaction was stopped with 4 mM cysteine and residual IANBD-amide was removed by dialysis (50 mM Tris-HCl pH 6.8, 150 mM NaCl, and 1 mM DTT). NBD-labeled proteins were mixed with equal volume of glycerol and stored at −80°C before analysis.

### Liposome preparations {#sec4.4.8}

Lipids were mixed at the desired molar ratio and the organic solvent was removed in a rotary evaporator. The lipid films were hydrated in buffer A (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.2 mM EDTA, and 1 mM EGTA) for 30 min at room temperature or at 65°C for liposomes containing saturated lipids. The suspensions were sonicated in a bath sonicator or extruded through polycarbonate filters of the indicated pore size using a mini-extruder (Avanti Polar Lipids). Liposomes were used within 1 day.

### Real-time PIP 5-kinase assay {#sec4.4.9}

PIP 5-kinase reactions were carried out in buffer A (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.2 mM EDTA, and 1 mM EGTA) supplemented with 2 mM MgCl~2~ and 80 μM ATP and measured with a Fluoromax spectrometer (HORIBA Scientific). Briefly, the sample (150 μl) containing liposomes (400 μM total lipids) were mixed with PIP5K (final conc. 60 nM except as indicated in Figure S2C and S3G-H) and NBD-PH~PLCδ~ (final conc. 400 nM) in a 200 μL quartz cell. After 5 min, 15 μL of MgCl~2~ was added (final conc. 2 mM). At 2 min later, the reaction was initiated by adding 15 μL of ATP solution (final conc. 80 μM). NBD fluorescence (ex/em 468 nm/530 nm) was recorded every second. The excitation and emission slits were set at 5 nm bandwidths. We calculated an increase in signal of NBD fluorescence (ΔEm~530,\ raw\ data~) from that measured before ATP addition. To subtract the contribution of liposomes alone, a background signal of NBD fluorescence (ΔEm~530,\ BG~) was measured with the NBD-PH~PLCδ~ in the presence of 0% PI4P liposomes. Finally, an NBD signal increase dependently of PIP5K reaction was calculated by using this equation: ΔEm~530~ = ΔEm~530,\ raw\ data~ - ΔEm~530,\ BG~. Data were analyzed by using RStudio or an Excel VBA macro. To determine initial velocities of PIP5K reaction at different substrate concentrations, ΔEm~530~ data were analyzed by using GraphPad Prism software and a slope of the initial portion of the regression curve was used as an individual initial velocity. Then, initial velocities of PIP5K reaction were fitted to an allosteric sigmoidal kinetic model to obtain the apparent K~m~ and V~max~ values by using Graphpad Prsim software.

### ADP-Glo kinase assay {#sec4.4.10}

PIP 5-kinase reactions were carried out as in the real-time assays except with 8 μM ATP. ADP-Glo assays were performed according to the manufacturer's instructions. Briefly, a part of reaction mixture (25 μl) was mixed with 25 μL of ADP-Glo reagent. After a 40 min of incubation, 50 μL of Kinase Detection Reagent was added and further incubated for 30 min. Luminescence signal was recorded using a Tecan infinite F200 microplate reader. Non-specific background signals independent of PIP5K activity were subtracted by using liposomes lacking PI4P.

### Malachite green phosphate assay {#sec4.4.11}

A malachite-molybdate solution was made freshly by mixing a malachite green solution (0.03175% malachite green and 0.35% polyvinyl alcohol) and molybdate solution (3.46% ammonium molybdate and 11.2% (v/v) concentrated sulfuric acid) at a ratio of 64 to 86. To measure free phosphate levels during the PIP5K reaction course, 100 μL of PIP5K reaction mixture was mixed with 150 μL of malachite-molybdate solution. Absorbance at 595 nm was measured using a Tecan infinite F200 microplate reader. Phosphate levels were determined using a phosphate standard.

### Liposome sedimentation assay {#sec4.4.12}

Sedimentation assays were carried out in buffer A (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.2 mM EDTA, and 1 mM EGTA) supplemented with 2 mM MgCl~2~. Briefly, liposomes of defined compositions (400 μM total lipids) were mixed with zPIP5K (final conc. 130 nM). After 15 min at room temperature, the mixture was centrifuged at 20,800 x *g* for 30 min. The supernatant and pellet fractions were solubilized with SDS-PAGE sample buffer and heated at 95°C for 5 min. The supernatant and pellet fractions were separated by SDS-PAGE and transferred to nitrocellulose membranes. Immunoblot analysis was performed with an anti-His antibody and visualized with Super-Signal West Pico Chemiluminescent substrate to detect the zPIP5K-His protein. Signal intensities were analyzed using the LAS-4000mini image analyzer and Fiji/ImageJ.

### *in vitro* FRET assays {#sec4.4.13}

Liposomes (400 μM total lipids) were mixed with CFP-C2~Lact~ (400 nM) and Venus-P4C (400 nM) in buffer A (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.2 mM EDTA, and 1 mM EGTA) supplemented with 2 mM MgCl~2~. After incubation for 5 min, fluorescence spectra were recorded using a Fluoromax spectrometer. CFP signal (ex/em 433 nm/476 nm), Venus signal (ex/em 505 nm/ 528 nm), and FRET signal (ex/em 433 nm/528 nm) were measured. The excitation and emission slits were set at 5 nm bandwidths. We analyzed CFP or Venus proteins alone at several different concentrations and found that 42.38% of CFP signal and 3.206% of Venus signal bled through into the FRET signal in our experimental conditions. Based on those results, corrected FRET values were calculated using the following equation: cFRET = FRET -- 0.4238∗CFP -- 0.03206∗Venus.

### Quantitative membrane binding assay using Dansyl-PE liposomes {#sec4.4.14}

Liposomes (400 μM total lipids) containing 2 mol% Dansyl-PE were mixed with Venus-C2~Lact~ (400 nM) or Venus-P4C (1 μM) in buffer A (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.2 mM EDTA, and 1 mM EGTA) supplemented with 2 mM MgCl~2~. After incubation for 5 min, fluorescence spectra were recorded using a Fluoromax spectrometer. Tryptophan (Trp; ex/em 280 nm/350 nm), Dansyl (ex/em 330 nm/ 510 nm), and FRET signals (ex/em 280 nm/500 nm) were measured. The excitation and emission slits were set at 5 nm bandwidths. We analyzed Venus-C2~Lact~, Venus-P4C or Dansyl-PE liposomes alone at several different concentrations and calculated a background signal and amount of bleed-through signals into the FRET signal in our experimental conditions. Based on those results, corrected FRET values were calculated using the following equation: cFRET = FRET -- 0.0678∗Trp -- 0.3316∗Dansyl -- 1674, for Venus-C2~Lact~; cFRET = FRET -- 0.2195∗Trp -- 0.3316∗Dansyl -- 1674, for Venus-P4C.

### Plasma membrane integrity assays {#sec4.4.15}

Yeast strains were grown to midlog phase at 26°C and shifted to 42°C for 15 min as indicated. 1 OD~600~ equivalent of cells was pelleted and resuspended in PBS, and cells were stained with propidium iodide for 15 min. Cells were then washed twice with ddH~2~O and analyzed by flow cytometry (BD Accuri C6). For each condition, 50,000 cells were counted in duplicate in three independent experiments. Background was determined by analyzing each of the cell strains at the indicated temperatures prior to staining with propidium iodide.

### Atomistic simulations {#sec4.4.16}

We modeled a 24-mer peptide (LQSYRLVKKLEHSWKALLHDGDTV) from the phsophatidylinositol-4-phosphate 5 kinase (Q503I3) into a α-helical conformation using the UCSF CHIMERA software package and aligned it along the x axis, centered at the origin. We used CHARMM-GUI to set up the atomistic plasma membrane model systems with CHARMM36m ([@bib28]). All simulations were run using the GROMACS 2018 software package. N- and C-termini were neutralized (residue types NNEU and CNEU, respectively), whereas H391 and H398 were protonated. We embedded the peptide into the lipid headgroup region by translating it by 16 Å along the z axis. Ions were added to a total concentration of 150 mM NaCl, after neutralizing the system with counter ions. The resulting membrane containing cholesterol has the following molar composition (the number in brackets reports the number of molecules for each lipid species): 69% mol POPC \[414\], 20% mol cholesterol \[120\], 10% mol DOPS \[60\], 1% mol polyunsaturated bPI4P (SA-PI4P) \[6\]. We energy minimized all systems with steepest descent and performed equilibration in subsequent steps. First the system was equilibrated in a canonical (NVT) ensemble with an integration time step of 1 fs for 25 ps, maintaining a constant temperature of 310 K with the Berendsen thermostat. In this phase, position restraints of 1000 kJ mol^-1^nm^-2^ were applied to all lipid heavy atoms, whereas restraints on protein backbone heavy atoms were lowered from 4000 to 2000 kJ mol^-1^nm^-2^. The Berendsen barostat was used to keep a constant pressure of 1 bar in the isothermal isobaric (NPT) equilibration for the first 25 ps with a time step of 1 fs ([@bib6]). All subsequent equilibration steps were performed for 300 ps with a time step of 2 fs. Here, lipid position restraints were decreased from 400 to 0 kJ mol^-1^nm^-2^ and protein position restraints were decreased from 1000 to 200 kJ mol^-1^nm^-2^. No restraints were applied on the systems during the production simulations. The temperature and pressure were kept constant at 310 K and 1 bar using the Velocity Rescale thermostat ([@bib8]) and Parrinello-Rahman barostat ([@bib48]) with a semiisotropic pressure coupling, applying each on the protein, solvent and membrane with characteristic times of 1 and 5 ps, respectively. All non-bonded interactions were cutoff at 1.2 nm throughout simulations.

### Analysis of lipid localization {#sec4.4.17}

We discretized the position of each lipid on a two-dimensional grid by using the x and y coordinates of phosphate moieties (phospholipids) or oxygen atoms (cholesterol), using a bin width of 1 Å and sampling every 250 ps. We used an in-plane least-square fit of the protein backbone C atoms of the 5K~loop~ helical peptide to a reference structure aligned along the x axis, to obtain a two-dimensional in-place rotational angle for every frame. The two-dimensional grid was rotated by the calculated angle about the axis orthogonal to the lipid bilayer plane and interpolated using a third order spline. The grid was extended and cropped after the rotation in every frame, taking into account periodic boundary conditions, to keep the original dimensions. Finally, we obtained the reported lipid localization densities by averaging all two-dimensional grids along the entire trajectory ignoring the first 100 ns.

### Trajectory analysis {#sec4.4.18}

We used VMD, GROMACS, MDAnalysis, NumPy, SciPy, IPython, and Matplotlib for the analysis and visualization of trajectories.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical analysis was carried out using GraphPad Prism 6. To compare the mean of two groups, an unpaired two-tailed t test was used. To compare the mean of multiple groups, we used one-way ANOVA followed by Tukey-Kramer multiple comparisons.

Data and Code Availability {#sec4.6}
--------------------------

The raw imaging data have been deposited in Mendeley Data and can be accessed: <https://doi.org/10.17632/x96sprmwrg.1>.
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